157 related articles for article (PubMed ID: 7965822)
1. Antinociceptive and respiratory effects of nalbuphine in rhesus monkeys.
Gerak LR; Butelman ER; Woods JH; France CP
J Pharmacol Exp Ther; 1994 Nov; 271(2):993-9. PubMed ID: 7965822
[TBL] [Abstract][Full Text] [Related]
2. Behavioral effects and receptor binding affinities of fentanyl derivatives in rhesus monkeys.
France CP; Gerak LR; Flynn D; Winger GD; Medzihradsky F; Bagley JR; Brockunier LL; Woods JH
J Pharmacol Exp Ther; 1995 Jul; 274(1):17-28. PubMed ID: 7616395
[TBL] [Abstract][Full Text] [Related]
3. Opioid thermal antinociception in rhesus monkeys: receptor mechanisms and temperature dependency.
Walker EA; Butelman ER; DeCosta BR; Woods JH
J Pharmacol Exp Ther; 1993 Oct; 267(1):280-6. PubMed ID: 7901396
[TBL] [Abstract][Full Text] [Related]
4. Apparent pA2 analysis on the respiratory depressant effects of alfentanil, etonitazene, ethylketocyclazocine (EKC) and Mr2033 in rhesus monkeys.
Butelman ER; France CP; Woods JH
J Pharmacol Exp Ther; 1993 Jan; 264(1):145-51. PubMed ID: 8093721
[TBL] [Abstract][Full Text] [Related]
5. In vivo determination of mu opioid receptor turnover in rhesus monkeys after irreversible blockade with clocinnamox.
Zernig G; Butelman ER; Lewis JW; Walker EA; Woods JH
J Pharmacol Exp Ther; 1994 Apr; 269(1):57-65. PubMed ID: 8169852
[TBL] [Abstract][Full Text] [Related]
6. Opioid antinociception in ovariectomized monkeys: comparison with antinociception in males and effects of estradiol replacement.
Negus SS; Mello NK
J Pharmacol Exp Ther; 1999 Sep; 290(3):1132-40. PubMed ID: 10454487
[TBL] [Abstract][Full Text] [Related]
7. Discriminative stimulus effects of nalbuphine in rhesus monkeys.
Gerak LR; France CP
J Pharmacol Exp Ther; 1996 Feb; 276(2):523-31. PubMed ID: 8632318
[TBL] [Abstract][Full Text] [Related]
8. Ventilation in morphine-maintained rhesus monkeys. II: Tolerance to the antinociceptive but not the ventilatory effects of morphine.
Paronis CA; Woods JH
J Pharmacol Exp Ther; 1997 Jul; 282(1):355-62. PubMed ID: 9223574
[TBL] [Abstract][Full Text] [Related]
9. Butorphanol: characterization of agonist and antagonist effects in rhesus monkeys.
Butelman ER; Winger G; Zernig G; Woods JH
J Pharmacol Exp Ther; 1995 Feb; 272(2):845-53. PubMed ID: 7853203
[TBL] [Abstract][Full Text] [Related]
10. Chronic l-alpha-acetylmethadol (LAAM) in rhesus monkeys: tolerance and cross-tolerance to the antinociceptive, ventilatory, and rate-decreasing effects of opioids.
Brandt MR; France CP
J Pharmacol Exp Ther; 2000 Jul; 294(1):168-78. PubMed ID: 10871309
[TBL] [Abstract][Full Text] [Related]
11. Buprenorphine antagonism of mu opioids in the rhesus monkey tail-withdrawal procedure.
Walker EA; Zernig G; Woods JH
J Pharmacol Exp Ther; 1995 Jun; 273(3):1345-52. PubMed ID: 7791107
[TBL] [Abstract][Full Text] [Related]
12. Respiratory effects of opioid full and partial agonists in rhesus monkeys.
Liguori A; Morse WH; Bergman J
J Pharmacol Exp Ther; 1996 Apr; 277(1):462-72. PubMed ID: 8613955
[TBL] [Abstract][Full Text] [Related]
13. Effects of gonadal steroid hormone treatments on opioid antinociception in ovariectomized rhesus monkeys.
Negus SS; Mello NK
Psychopharmacology (Berl); 2002 Jan; 159(3):275-83. PubMed ID: 11862360
[TBL] [Abstract][Full Text] [Related]
14. Mirfentanil: pharmacological profile of a novel fentanyl derivative with opioid and nonopioid effects.
France CP; Winger G; Medzihradsky F; Seggel MR; Rice KC; Woods JH
J Pharmacol Exp Ther; 1991 Aug; 258(2):502-10. PubMed ID: 1650830
[TBL] [Abstract][Full Text] [Related]
15. Behavioral effects of 6-methylene naltrexone (nalmefene) in rhesus monkeys.
France CP; Gerak LR
J Pharmacol Exp Ther; 1994 Sep; 270(3):992-9. PubMed ID: 7932212
[TBL] [Abstract][Full Text] [Related]
16. Methoclocinnamox: agonist and antagonist effects of a novel long-lasting opioid in rhesus monkeys.
Butelman ER; Lewis JW; Woods JH
J Pharmacol Exp Ther; 1996 Nov; 279(2):934-8. PubMed ID: 8930202
[TBL] [Abstract][Full Text] [Related]
17. Antinociceptive effects of cocaine/opioid combinations in rhesus monkeys.
Gatch MB; Negus SS; Butelman ER; Mello NK
J Pharmacol Exp Ther; 1995 Dec; 275(3):1346-54. PubMed ID: 8531102
[TBL] [Abstract][Full Text] [Related]
18. In vivo apparent pA2 analysis for naltrexone antagonism of discriminative stimulus and analgesic effects of opiate agonists in rats.
Walker EA; Makhay MM; House JD; Young AM
J Pharmacol Exp Ther; 1994 Nov; 271(2):959-68. PubMed ID: 7965818
[TBL] [Abstract][Full Text] [Related]
19. Clocinnamox inhibits the intravenous self-administration of opioid agonists in rhesus monkeys: comparison with effects on opioid agonist-mediated antinociception.
Zernig G; Lewis JW; Woods JH
Psychopharmacology (Berl); 1997 Feb; 129(3):233-42. PubMed ID: 9084061
[TBL] [Abstract][Full Text] [Related]
20. Agonist and antagonist effects of dynorphin A-(1-13) in a thermal antinociception assay in rhesus monkeys.
Butelman ER; France CP; Woods JH
J Pharmacol Exp Ther; 1995 Oct; 275(1):374-80. PubMed ID: 7562573
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
